Cullinan Therapeutics, Inc.
CGEM
Revenue
0.00
0.000.00%
3 Months ChangeAssets
621.82M
▼-31.43M▼-4.81%
3 Months ChangeLiabilities
31.50M
▲6.10M▲24.04%
3 Months ChangeFree Cash Flow
-38.25M
▲12.91M▲25.23%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-16
Form 8-K
ID: 0000950170-24-114841
2024-09-17
Form 8-K
ID: 0000950170-24-107011
2024-08-08
Form 10-Q
ID: 0000950170-24-093320
2024-08-08
Form 8-K
ID: 0000950170-24-093314
2024-06-27
Form 8-K
ID: 0000950170-24-078554
2024-06-03
Form 8-K
ID: 0000950170-24-067662
2024-05-23
Form 8-K
ID: 0000950170-24-064025
2024-05-15
Form 10-Q
ID: 0000950170-24-060535
2024-05-15
Form 8-K
ID: 0000950170-24-060481
2024-04-29
Form 8-K
ID: 0000950170-24-049436